• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher Pierce

Location
Wilmington, DE
Summary
The estimated net worth of Christopher Pierce is at least $14,138 dollars as of 07 Sep 2021. Christopher Pierce is the EVP and Chief of Business Oper of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $14.1K.
Signature
/s/ Brian Piper, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Christopher Pierce files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Christopher Pierce

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PRLD Prelude Therapeutics Inc EVP and Chief of Business Oper $14,138 02 Sep 2021

Insider Transactions Reported by Christopher Pierce:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.